Table 4 | Enhanced Perinatal Surveillance United States, 1999–2001 | Reports | Statistics and Surveillance | Topics

Home

About CDC

Press Room

A-Z Index

CDC en Español

CDC Home > HIV/AIDS > Topics > Statistics and Surveillance > Reports > Enhanced Perinatal Surveillance United States, 1999–2001

Table 4. Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt and year of infant's birth, 1999–2001—24 areas conducting Enhanced Perinatal Surveillance

View PDF


	Year of infant's birth						Cumulative total
	1999		2000		2001		Cumulative total
Receipt of antiretroviral therapy	No.	%	No.	%	No.	%	No.	%
Prenatal period
Yes	2280	77	2470	80	1932	81	6682^a	79
No	530	18	473	15	349	15	1352	16
Unknown	160	5	153	5	101	4	414	5

Intrapartum period
Yes	2190	74	2395	77	1888	79	6473	77
No	430	15	387	13	292	12	1109	13
Unknown	350	12	314	10	202	9	866	10

Neonatal period^b
Yes	2627	89	2886	93	2219	93	7732	92
No	245	8	136	4	86	4	467	6
Unknown	98	3	74	2	77	3	249	3

Total	2970		3096		2382		8448

Note. Because of rounding, column percentages may not total 100. The numbers of women receiving antiretroviral therapy prenatally and intrapartum are not mutually exclusive.


^a	Includes 6338 women who received prenatal care and 344 women who did not receive prenatal care or for whom prenatal care is unknown.
^b	Includes 1 HIV-exposed infant per pregnancy with the assumption that all infants of a multiple birth received the same antiretroviral therapy.

Last Modified: September 19, 2006
Last Reviewed: September 19, 2006
Content Source:
Divisions of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

Home

Policies and Regulations

Disclaimer

e-Government

FOIA

Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348, 24 Hours/Every Day - cdcinfo@cdc.gov.

Department of Health
and Human Services